Acute Kidney Disease Etiologic Evaluation

Authored by Sourabh Sharma, published on 2026-11-12 16:26:43.0

Life-Threatening AKI Complication or Urgent Kidney Support Needed?
- Stabilize and Obtain Emergency Nephrology or Critical Care Support
  - Establish Baseline and Chronicity; Assess SCr/UO Trends, Volume, Exposures, Urine, and Systemic Clues
    - Classify AKI, AKD, or CKD
      - Which Etiologic Category Best Fits the Data?
        
        Obtain Bladder Scan or Renal Imaging; Is Obstruction Present?
        
        Relieve Obstruction and Obtain Urgent Urology Support
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Which Intrinsic or Systemic AKD Phenotype Predominates?
        
        Order Glomerular Serologies and Monoclonal Studies; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Evaluate Ischemic, Toxic, Pigment, and Crystal Injury; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Review Drugs, Infection, and Autoimmune Clues; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Evaluate TMA, Vascular, and Systemic Disease; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Correct Hemodynamic Drivers; Did Kidney Function Improve?
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Which Intrinsic or Systemic AKD Phenotype Predominates?
        
        Order Glomerular Serologies and Monoclonal Studies; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Evaluate Ischemic, Toxic, Pigment, and Crystal Injury; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Review Drugs, Infection, and Autoimmune Clues; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Evaluate TMA, Vascular, and Systemic Disease; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Which Intrinsic or Systemic AKD Phenotype Predominates?
        
        Order Glomerular Serologies and Monoclonal Studies; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Evaluate Ischemic, Toxic, Pigment, and Crystal Injury; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Review Drugs, Infection, and Autoimmune Clues; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Evaluate TMA, Vascular, and Systemic Disease; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
      - Chronic Abnormality Without Acute Change: Follow CKD Pathway
- Establish Baseline and Chronicity; Assess SCr/UO Trends, Volume, Exposures, Urine, and Systemic Clues
  - Classify AKI, AKD, or CKD
    - Which Etiologic Category Best Fits the Data?
      - Obtain Bladder Scan or Renal Imaging; Is Obstruction Present?
        
        Relieve Obstruction and Obtain Urgent Urology Support
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Which Intrinsic or Systemic AKD Phenotype Predominates?
        
        Order Glomerular Serologies and Monoclonal Studies; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Evaluate Ischemic, Toxic, Pigment, and Crystal Injury; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Review Drugs, Infection, and Autoimmune Clues; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Evaluate TMA, Vascular, and Systemic Disease; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
      - Correct Hemodynamic Drivers; Did Kidney Function Improve?
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Which Intrinsic or Systemic AKD Phenotype Predominates?
        
        Order Glomerular Serologies and Monoclonal Studies; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Evaluate Ischemic, Toxic, Pigment, and Crystal Injury; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Review Drugs, Infection, and Autoimmune Clues; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Evaluate TMA, Vascular, and Systemic Disease; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
      - Which Intrinsic or Systemic AKD Phenotype Predominates?
        
        Order Glomerular Serologies and Monoclonal Studies; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Evaluate Ischemic, Toxic, Pigment, and Crystal Injury; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Review Drugs, Infection, and Autoimmune Clues; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Evaluate TMA, Vascular, and Systemic Disease; Is Biopsy Needed?
        
        Obtain Kidney Biopsy With Nephrology After Safety Review
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
        
        Serially Reassess SCr/eGFR, Urine Output, Urinalysis, and Proteinuria Through 3 Months
        
        Recovery, Persistent AKD, or CKD at Follow-Up?
        
        Document Recovery and Continue Risk-Based Kidney Follow-Up
        
        Persistent AKD: Escalate Nephrology Evaluation Through 3 Months
        
        Classify CKD and Transition to CKD Management
    - Chronic Abnormality Without Acute Change: Follow CKD Pathway

tos privacy